Author: [AUTHOR] Published on 2/11/2020 11:05:00 AM
FDA Office of Clinical Pharmacology Announces Availability of 2019 Annual Reports
The Food and Drug Administration (FDA), Office of Clinical Pharmacology (OCP) announces the availability of the 2019 OCP and Division of Applied Regulatory Science (DARS) Annual Reports. OCP is a dynamic, purpose-driven organization dedicated to promoting and protecting global public health through the application of clinical pharmacology and translational medicine principles. OCP's mission is to play a pivotal role in advancing development of innovative new medicines by applying state-of-the-art scientific principles; and promote therapeutic optimization and individualization through best practices in research, policy development, and drug evaluation throughout the product lifecycle. The 2019 OCP and DARS Annual Reports highlight OCP's important work towards a vision of improving public health by building and translating knowledge of drug-response into patient-centered regulatory decisions of the highest quality.
DARS is a multidisciplinary research division of OCP that performs mission-critical applied research and review across the translational research spectrum, including in vitro
and in vivo
laboratory research, in silico
computational modeling and informatics, and integrated clinical research covering clinical pharmacology, experimental medicine, and postmarket analyses.
Learn more about OCP's diverse functional responsibilities, value-focused culture, 2019 achievements, and 2020 outlook found in the reports at the following links: 2019 OCP Annual Report: https://go.usa.gov/xdKbc
, 2019 DARS Annual Report: https://go.usa.gov/xdKbQ
. Past OCP annual reports can be found at: https://go.usa.gov/xd9fu
The Office of Clinical Pharmacology (OCP) is pleased to offer the e-mail subscription service Clinical Pharmacology Corner. This is a free service from FDA to provide occasional updates from OCP regarding newly approved therapies, new regulatory and scholarly publications, upcoming events and other items of interest. Subscribe today at http://go.fda.gov/subscriptionmanagement
(note: this link does not work with Internet Explorer) and select Clinical Pharmacology Corner under Drugs.
We always welcome your thoughts regarding the format, content, and utility of this communication. Comments may be sent via email to firstname.lastname@example.org
This communication was prepared by Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA.